David Walt - Quanterix Corp Independent Director
| QTRX Stock | USD 6.04 0.18 3.07% |
Director
Dr. David R. Walt is Independent Director of the Company. Dr. Walt was our founding scientist and serves as chairman of our scientific advisory board. Dr. Walt currently serves as a faculty member at Harvard Medical School in the Department of Pathology at the Brigham and Women Hospital and is a core faculty member of the Wyss Institute for Biologically Inspired Engineering. He is also a Howard Hughes Medical Institute Professor. He previously served as University Professor, Professor of Biomedical Engineering, Professor of Genetics, Professor of Neuroscience, Professor of Cell and Molecular Biology, and Professor of Oral Medicine at Tufts University, from 19812017. Dr. Walt was also the founding scientist of Illumina, Inc. and served as a member of the board of its directors from 19982016 and now serves as chairman of its scientific advisory board. He was also a founder and currently serves as a member of the board of directors of Ultivue, Inc., and Arbor, Inc., and serves as a member of the board of directors of Exicure, Inc. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical sensors, microwell arrays and single molecule detection. He is a member of the U.S. National Academy of Engineering, U.S. National Academy of Medicine, American Academy of Arts and Sciences, a fellow of the American Institute for Medical and Biological Engineering, a fellow of the National Academy of Inventors, and a fellow of the American Association for the Advancement of Science since 2007.
| Age | 72 |
| Tenure | 18 years |
| Professional Marks | Ph.D |
| Address | Building 1, Billerica, MA, United States, 01821 |
| Phone | 617 301 9400 |
| Web | https://www.quanterix.com |
David Walt Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Walt against Quanterix Corp stock is an integral part of due diligence when investing in Quanterix Corp. David Walt insider activity provides valuable insight into whether Quanterix Corp is net buyers or sellers over its current business cycle. Note, Quanterix Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Quanterix Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Walt over three months ago Acquisition by David Walt of 15821 shares of Quanterix Corp at 10.76 subject to Rule 16b-3 | ||
David Walt over six months ago Acquisition by David Walt of 7435 shares of Quanterix Corp subject to Rule 16b-3 | ||
David Walt over a year ago Acquisition by David Walt of 2947 shares of Quanterix Corp subject to Rule 16b-3 |
Quanterix Corp Management Efficiency
The company has return on total asset (ROA) of (0.0938) % which means that it has lost $0.0938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1451) %, meaning that it created substantial loss on money invested by shareholders. Quanterix Corp's management efficiency ratios could be used to measure how well Quanterix Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.1 in 2025. Return On Capital Employed is likely to rise to -0.14 in 2025. At this time, Quanterix Corp's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 5.7 M in 2025, whereas Total Assets are likely to drop slightly above 265.3 M in 2025.Similar Executives
| Found 3 records | DIRECTOR Age | ||
| CPA ACA | Stoke Therapeutics | 59 | |
| Kaitlyn Brosco | Vicarious Surgical | N/A | |
| Doug Snow | Stoke Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0938 |
Quanterix Corp Leadership Team
Elected by the shareholders, the Quanterix Corp's board of directors comprises two types of representatives: Quanterix Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quanterix. The board's role is to monitor Quanterix Corp's management team and ensure that shareholders' interests are well served. Quanterix Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quanterix Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jerzy Olejnik, Chief Officer | ||
| David Duffy, CTO, Vice President Research | ||
| Mary Cortizas, VP CRO | ||
| Laurie Churchill, General VP | ||
| Bruce Bal, Vice President - Operations, Service and Quality | ||
| Mark Roskey, Vice President General Manager | ||
| David Walt, Independent Director | ||
| Daniel Pikora, Chief Officer | ||
| Darrin MBA, Senior Officer | ||
| Michael Miller, Chief Officer | ||
| Michael Doyle, Executive Finance | ||
| Naren Bhat, Senior Strategy | ||
| David Panzerella, Vice Sales | ||
| Alexandra Phillips, Senior Officer | ||
| Laurie JD, General VP | ||
| Erica Bell, Chief Officer | ||
| Masoud Toloue, CEO President | ||
| Vandana CPA, Chief Officer |
Quanterix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quanterix Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0938 | ||||
| Profit Margin | (0.35) % | ||||
| Operating Margin | (0.87) % | ||||
| Current Valuation | 42.93 M | ||||
| Shares Outstanding | 46.65 M | ||||
| Shares Owned By Insiders | 6.58 % | ||||
| Shares Owned By Institutions | 72.50 % | ||||
| Number Of Shares Shorted | 3.62 M | ||||
| Price To Book | 0.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quanterix Stock Analysis
When running Quanterix Corp's price analysis, check to measure Quanterix Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quanterix Corp is operating at the current time. Most of Quanterix Corp's value examination focuses on studying past and present price action to predict the probability of Quanterix Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quanterix Corp's price. Additionally, you may evaluate how the addition of Quanterix Corp to your portfolios can decrease your overall portfolio volatility.